Related Experiment Video
Updated: May 21, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
TAOK1 promotes filament formation in HR repair through phosphorylating USP7
Tian-Chen Zhu1,2, Zhang-Ping He3, Shu-Ting Li1,2
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510000, China.
Abstract:
Poly-ADP-ribose polymerase (PARP) inhibitors are vital therapeutic agents that exploit synthetic lethality, particularly effective in tumors with homologous recombination (HR) defects. However, broadening their clinical utility remains a significant challenge. In this study, we conducted a high-throughput kinase inhibitor screen to identify potential targets exhibiting synthetical lethality with PARP inhibitors. Our results show that thousand and one amino acid protein kinase 1 (TAOK1) plays a pivotal role in the DNA damage response by phosphorylating ubiquitin specific peptidase 7 (USP7), thereby promoting its enzymatic activity and preventing the ubiquitylation and subsequent degradation of RAD51, a crucial protein in the filament formation of HR repair. Notably, genetic depletion or pharmacological inhibition of TAOK1, as well as blocking peptide targeting the USP7 phosphorylation site, impaired USP7 function, leading to RAD51 degradation, disruption of HR repair, and increased tumor cell and sensitivity to PARP inhibition. This study highlights TAOK1 as a critical regulator of HR repair pathway in human cancer cells and presents a therapeutic strategy overcoming resistance to PARPi inhibitors. These findings support the potential clinical application of combining PARP inhibitors with TAOK1 inhibition or peptide treatment to improve therapeutic outcomes.
Insights
Thousand and one amino acid protein kinase 1 (TAOK1) inhibition enhances PARP inhibitor efficacy in cancer. Blocking TAOK1 or its interaction with USP7 degrades RAD51, disrupting DNA repair and increasing cancer cell sensitivity to PARP inhibitors.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Poly-ADP-ribose polymerase (PARP) inhibitors are key cancer therapies for tumors with homologous recombination (HR) defects.
- Expanding the clinical use of PARP inhibitors is limited by resistance mechanisms.
Purpose of the Study:
- To identify novel targets for synthetic lethality with PARP inhibitors.
- To investigate the role of thousand and one amino acid protein kinase 1 (TAOK1) in DNA damage response and PARP inhibitor resistance.
Main Methods:
- High-throughput kinase inhibitor screening to find targets synthetically lethal with PARP inhibitors.
- Genetic depletion and pharmacological inhibition of TAOK1.
- Assessment of RAD51 stability and HR repair function.
- Evaluation of cancer cell sensitivity to PARP inhibition.
Main Results:
- TAOK1 phosphorylates ubiquitin specific peptidase 7 (USP7), enhancing its activity.
- USP7 activity prevents RAD51 ubiquitylation and degradation, preserving HR repair.
- Inhibiting TAOK1 or USP7 function leads to RAD51 degradation and HR repair defects.
- TAOK1 inhibition or USP7 blocking peptides increase cancer cell sensitivity to PARP inhibitors.
Conclusions:
- TAOK1 is a critical regulator of the HR repair pathway in human cancer cells.
- Combining PARP inhibitors with TAOK1 inhibition or USP7-targeting peptides offers a strategy to overcome PARPi resistance.
- This approach holds potential for improving therapeutic outcomes in cancer treatment.
More Related Videos
10:44Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...